PE 22:1/22:1: A Key Component for Nanomedicine Development
The field of nanomedicine is revolutionizing healthcare by enabling more precise and effective therapeutic interventions. At the core of many nanomedicine platforms are lipid-based nanoparticles, such as liposomes and micelles, which serve as versatile carriers for drugs, genetic material, and imaging agents. A crucial component in the formulation of these advanced delivery systems is the phospholipid 1,2-Di(cis-13-docosenoyl)-sn-glycero-3-phosphoethanolamine (PE 22:1/22:1). Its unique structural characteristics make it highly valuable for nanomedical applications.
As a specialized manufacturer and supplier of high-grade lipids, NINGBO INNO PHARMCHEM provides PE 22:1/22:1 to support the development of next-generation nanomedicines. The unsaturated fatty acid chains in this phospholipid contribute to the fluidity and stability of the resulting nanoparticles. This fluidity is often essential for efficient drug release and for the interaction of the nanoparticles with cellular targets. For nanomedicine researchers looking to buy reliable and pure PE 22:1/22:1, our commitment to quality assurance as a manufacturer in China ensures that you receive materials that meet rigorous standards.
The ability to form stable structures like liposomes and micelles is a hallmark of PE 22:1/22:1. These structures are critical for encapsulating hydrophilic or hydrophobic drugs, protecting them from premature degradation in the bloodstream, and ensuring their delivery to the intended site of action. By purchasing PE 22:1/22:1 from NINGBO INNO PHARMCHEM, you are securing a vital ingredient that can significantly impact the performance of your nanomedicine formulations. We offer competitive pricing, making it feasible for research institutions and pharmaceutical companies to buy in quantities needed for extensive development.
Our role as a dedicated supplier in China allows us to efficiently serve the global nanomedicine community. We understand the importance of consistent quality and timely delivery for advancing groundbreaking research. Partner with NINGBO INNO PHARMCHEM to procure high-purity PE 22:1/22:1 and accelerate your nanomedicine development projects.
Perspectives & Insights
Agile Reader One
“The ability to form stable structures like liposomes and micelles is a hallmark of PE 22:1/22:1.”
Logic Vision Labs
“These structures are critical for encapsulating hydrophilic or hydrophobic drugs, protecting them from premature degradation in the bloodstream, and ensuring their delivery to the intended site of action.”
Molecule Origin 88
“By purchasing PE 22:1/22:1 from NINGBO INNO PHARMCHEM, you are securing a vital ingredient that can significantly impact the performance of your nanomedicine formulations.”